168 related articles for article (PubMed ID: 35775786)
1. Strengthening systems of care for people with or at risk for HIV, HCV and opioid use disorder: a call for enhanced data collection.
Eller AJ; DiDomizio EE; Madden LM; Oliva JD; Altice FL; Johnson KA
Ann Med; 2022 Dec; 54(1):1714-1724. PubMed ID: 35775786
[TBL] [Abstract][Full Text] [Related]
2. A Structural Competency Curriculum for Primary Care Providers to Address the Opioid Use Disorder, HIV, and Hepatitis C Syndemic.
Bagchi AD
Front Public Health; 2020; 8():210. PubMed ID: 32582612
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Medication Treatment of Opioid Use Disorder Among Primary Care Patients with Hepatitis C and HIV.
Tsui JI; Akosile MA; Lapham GT; Boudreau DM; Johnson EA; Bobb JF; Binswanger IA; Yarborough BJH; Glass JE; Rossom RC; Murphy MT; Cunningham CO; Arnsten JH; Thakral M; Saxon AJ; Merrill JO; Samet JH; Bart GB; Campbell CI; Loree AM; Silva A; Stotts AL; Ahmedani B; Braciszewski JM; Hechter RC; Northrup TF; Horigian VE; Bradley KA
J Gen Intern Med; 2021 Apr; 36(4):930-937. PubMed ID: 33569735
[TBL] [Abstract][Full Text] [Related]
4. Identifying Areas with Disproportionate Local Health Department Services Relative to Opioid Overdose, HIV and Hepatitis C Diagnosis Rates: A Study of Rural Illinois.
McLuckie C; Pho MT; Ellis K; Navon L; Walblay K; Jenkins WD; Rodriguez C; Kolak MA; Chen YT; Schneider JA; Zahnd WE
Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30893862
[No Abstract] [Full Text] [Related]
5. A novel mHealth application for improving HIV and Hepatitis C knowledge in individuals with opioid use disorder: A pilot study.
Ochalek TA; Heil SH; Higgins ST; Badger GJ; Sigmon SC
Drug Alcohol Depend; 2018 Sep; 190():224-228. PubMed ID: 30056321
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients.
Sivakumar A; Madden L; DiDomizio E; Eller A; Villanueva M; Altice FL
Int J Drug Policy; 2022 Mar; 101():103570. PubMed ID: 34954493
[TBL] [Abstract][Full Text] [Related]
8. Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?
Rich KM; Bia J; Altice FL; Feinberg J
Curr HIV/AIDS Rep; 2018 Jun; 15(3):266-275. PubMed ID: 29774442
[TBL] [Abstract][Full Text] [Related]
9. Defining a recovery-oriented cascade of care for opioid use disorder: A community-driven, statewide cross-sectional assessment.
Yedinak JL; Goedel WC; Paull K; Lebeau R; Krieger MS; Thompson C; Buchanan AL; Coderre T; Boss R; Rich JD; Marshall BDL
PLoS Med; 2019 Nov; 16(11):e1002963. PubMed ID: 31743335
[TBL] [Abstract][Full Text] [Related]
10. Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C.
Schranz AJ; Barrett J; Hurt CB; Malvestutto C; Miller WC
Curr HIV/AIDS Rep; 2018 Jun; 15(3):245-254. PubMed ID: 29796965
[TBL] [Abstract][Full Text] [Related]
11. Trends in Indicators of Injection Drug Use, Indian Health Service, 2010-2014 : A Study of Health Care Encounter Data.
Evans ME; Person M; Reilley B; Leston J; Haverkate R; McCollum JT; Apostolou A; Bohm MK; Van Handel M; Bixler D; Mitsch AJ; Haberling DL; Hatcher SM; Weiser T; Elmore K; Teshale EH; Weidle PJ; Peters PJ; Buchacz K
Public Health Rep; 2020; 135(4):461-471. PubMed ID: 32633599
[TBL] [Abstract][Full Text] [Related]
12. Viral Hepatitis and Human Immunodeficiency Virus Testing and Linkage to Care for Individuals Enrolled in an Opioid Treatment Program.
Rowan SE; Kamis KF; Beum R; Bryan K; Gawenus L; Colon Sanchez D; Hurley H
J Infect Dis; 2020 Sep; 222(Suppl 5):S384-S391. PubMed ID: 32877565
[TBL] [Abstract][Full Text] [Related]
13. Oral Prescription Opioids as a High-Risk Indicator for Hepatitis C Infection: Another Step Toward HCV Elimination.
Hack B; Timalsina U; Tefera E; Wilkerson B; Paku E; Fernandez S; Fishbein D
J Prim Care Community Health; 2021; 12():21501327211034379. PubMed ID: 34467805
[TBL] [Abstract][Full Text] [Related]
14. Examination of the Hepatitis C Virus care continuum among individuals with an opioid use disorder in substance use treatment.
Brown JL; Gause NK; Lewis D; Winhusen T
J Subst Abuse Treat; 2017 May; 76():77-80. PubMed ID: 28162850
[TBL] [Abstract][Full Text] [Related]
15. Infective Endocarditis Among Persons Aged 18-64 Years Living with Human Immunodeficiency Virus, Hepatitis C Infection, or Opioid Use Disorder, United States, 2007-2017.
Wong CY; Zhu W; Aurigemma GP; Furukawa N; Teshale EH; Huang YA; Peters PJ; Hoover KW
Clin Infect Dis; 2021 May; 72(10):1767-1781. PubMed ID: 32270861
[TBL] [Abstract][Full Text] [Related]
16. Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community: Progress, gaps, and future directions.
Taweh N; Schlossberg E; Frank C; Nijhawan A; Kuo I; Knight K; Springer SA
Int J Drug Policy; 2021 Oct; 96():103283. PubMed ID: 34020864
[TBL] [Abstract][Full Text] [Related]
17. A study protocol for Project I-Test: a cluster randomized controlled trial of a practice coaching intervention to increase HIV testing in substance use treatment programs.
Frimpong JA; Parish CL; Feaster DJ; Gooden LK; Nelson MC; Matheson T; Siegel K; Haynes L; Linas BP; Assoumou SA; Tross S; Kyle T; Liguori TK; Toussaint O; Annane D; Metsch LR
Trials; 2023 Sep; 24(1):609. PubMed ID: 37749635
[TBL] [Abstract][Full Text] [Related]
18. Effect of an mHealth Intervention on Hepatitis C Testing Uptake Among People With Opioid Use Disorder: Randomized Controlled Trial.
Hochstatter KR; Gustafson DH; Landucci G; Pe-Romashko K; Cody O; Maus A; Shah DV; Westergaard RP
JMIR Mhealth Uhealth; 2021 Feb; 9(2):e23080. PubMed ID: 33616545
[TBL] [Abstract][Full Text] [Related]
19. Missed Opportunities for HIV and Hepatitis C Screening Among Emergency Department Patients With Untreated Opioid Use Disorder.
Lyons MS; Chawarski MC; Rothman R; Whiteside L; Cowan E; Richardson LD; Hawk K; Tsui JI; Schwartz RP; O'Connor P; D'Onofrio G; Fiellin DA; Edelman EJ
J Addict Med; 2023 Mar-Apr 01; 17(2):210-214. PubMed ID: 36170184
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C Virus Screening among Medicaid-Insured Individuals with Opioid Use Disorder across Substance Use Disorder Treatment Settings.
Choi S; Healy S; Shapoval L; Forthal S; Neighbors CJ
Subst Use Misuse; 2021; 56(2):258-263. PubMed ID: 33345680
[No Abstract] [Full Text] [Related]
[Next] [New Search]
